The Ear, Nose, and Throat (ENT) and Facial Plastic Surgery Program at Children’s Minnesota is proud and excited to announce the additions of Asitha Jayawardena, MD and Andrew Redmann, MD. These amazing and talented surgeon-clinician scientists provide increased breadth and depth to our already nationally recognized program for the care and research of children with disorders of the ears, nose, and throat.
Children’s Minnesota RN, Latasha Lee, was appointed to the Minnesota Board of Nursing by Governor Tim Walz.
Children’s Minnesota recently joined together with 29 other health service providers and health care stakeholders throughout Minnesota to pledge to eliminate systemic racism and its negative impact on health and well-being.
As vice president of revenue services, Musser is responsible for all areas of revenue, including assessing, identifying and implementing strategies to improve current revenue cycle performance, in partnership with leaders and teams across the organization.
Children’s Minnesota CFO, Brenda McCormick, has been named an honoree for the 2020 Top Women in Finance award with Finance & Commerce magazine.
The Midwest Fetal Care Center in Minneapolis and The Mother Baby Center in St. Paul, both collaborations between Children’s Minnesota and Allina Health, have been recognized for interior design.
Children’s Minnesota CFO, Brenda McCormick, has been named an honoree for the 2020 CFO of the Year award by Minneapolis/St. Paul Business Journal. Brenda is among a few select honorees recognized for their vital role in making businesses, institutions and nonprofits successful.
Dr. Aimee Sznewajs, director of pediatric hospital medicine at Children’s Minnesota, presented at Grand Rounds for Allina’s regional hospitals and clinics on Wed., September 16: “COVID-19 and kids: Where we are today.”
David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was held on Sept. 10-11 and focused on practical considerations for the implementation of pharmacogenomics into clinical care.